News Focus
News Focus
icon url

onewon

03/29/07 10:15 AM

#521 RE: LoveThe Market #520

LTM .....

greetings, fellow UPBS holder.

IMHO, we have a financier getting fast easy $$$ out of the stock.

I still believe that Novar / UPBS did a REFI, with potentially costly results.

They put out that PR stating that they wiped out the original financing, BUT forgot to mention that the same guys are involved with this new stock/warrant "deal."

No wonder the boyz (J&D) can do 100MM$ financing on a former venture. Recycle $, while diluting shareholder share value.

JMHO
icon url

LoveThe Market

03/29/07 10:19 AM

#522 RE: LoveThe Market #520

$1.10 now? This PR seemed pretty good to me- what do you all think? LAK? Anyone?

Pinnacle Digest: Upstream Biosciences Inc: A New Look

Mar 29, 2007 (M2 PRESSWIRE via COMTEX) -- Upstream Biosciences Inc (OTCBB: UPBS) had a positive day in the markets Wednesday, as shareholders witnessed their company's share value increase 27.45% following the exchange of 2,319,544 shares trading hands before the sound of the closing bell. The share price ranged $0.26 throughout the day, finally settling on $1.30 at the end of the closing bell. In the article below, PinnacleDigest intends to further explore Upstream Biosciences and the exchange in which it resides. To continue this read and find out why our client base continues to grow, come explore www.pinnacledigest.com.
Recently, the Pinksheet exchange has come out with a new listing service called the OTCQX. The idea behind this new exchange is that it will bring an innovative trading, quotation and disclosure venue to the U.S. OTCQX provides issuers with an efficient and robust platform on which to list securities and access some of the deepest pools of liquidity in the world. OTCQX is designed to meet the particular needs of small to medium-sized U.S. public companies and foreign-exchange listed companies. With many companies turning to the Frankfurt exchange this new development could be very useful.

In corporate news, representatives from Upstream Biosciences Inc. an emerging player in the field of genetic diagnostics for cancer and the prediction of drug response, has appointed Philip Rice, former Treasurer for Transamerica and former Director of Dresdner Kleinworth Wasserstein to the Company's board of directors.

"Phil's extensive experience in corporate finance and investment banking will be a significant asset to the company," says Upstream CEO, Joel Bellenson. Rice, who earned his MBA at the University of California, Berkeley, has over twenty years of corporate finance and investment banking experience. His background includes executive/VP positions at Transamerica Corporation, Oracle, RateXchange Corporation, Goldman Sachs, SBC Warburg, AIG Financial Products Corp., and Morgan Stanley Capital Group. In addition, Rice has extensive experience in M&A, accounting and regulatory compliance, Sarbanes-Oxley compliance, SEC reporting, Internal Audit and Tax. PinnacleDigest is interested in this company's progress and will be watching for additional corporate developments in the coming months.

It is our purpose at PinnacleDigest to keep investors informed and up-to-date on the sector that most influences their company. We are constantly adding new features to our investment community and believe our unique investment approaches can benefit every investor. Understanding the exchange in which a company such as Upstream Biosciences Inc Corp resides, is key to the success of any investors' portfolio. To read this article in its entirety and to learn more about the OTCQX exchange, please visit www.pinnacledigest.com.

To continue with this report as well as other related articles, please visit www.pinnacledigest.com for a complimentary membership It should be stated that our membership requires no commitment to our service. If you would like to contact us please write to support@pinnacledigest.com.

PinnacleDigest has no vested interest in the company mentioned herein. This source of information is from an unbiased perspective. If you wish to become a member of www.pinnacledigest.com you will be gaining access to articles similar to this one and many other useful services we know you will find valuable. Keeping you educated and up-to-date with the market is one of our main purposes. Our approach in achieving this goal and our ability to consistently deliver high quality investment material is what defines our business model.

Investors seeking a distinctive approach to investing should also visit www.pinnacledigest.com for a complimentary membership About Pinnacle Digest

Pinnacledigest.com is an emerging online financial newsletter community. We put together informative material, capturing the information that we know will give you an edge to your portfolio and more specifically your investment approach.

Once a member of PinnacleDigest you will be able to access our complimentary full-length research reports on selected companies, our weekly volumes, and our market overviews. In addition to these services we are confident you will enjoy our many other services, as well as our main feature which is available to all our members.

We pride ourselves in having a multi purpose online magazine and encourage you to join our community.

This news release shall not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction.

All material herein was prepared by Pinnacledigest.com (Pinnacle Digest) based upon information believed to be reliable. The information contained herein is not guaranteed by Pinnacledigest.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Pinnacledigest.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Pinnacledigest.com may receive compensation in cash or shares from independent third parties or from the companies mentioned.

Pinnacledigest.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Pinnacledigest.com undertakes no obligation to update such statements.

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web Inquiries to info@m2.com.



(C)1994-2007 M2 COMMUNICATIONS LTD